pituitary adenylate cyclase-activating polypeptide (PACAP)
Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout
... Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) belong to the secretin–glucagon superfamily of peptides (Sherwood et ...
9
Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide (PACAP)
... mouse pituitary adenylate cyclase-activating polypeptide (PACAP; gene: Adcyap1) increased approximately ten fold in animals receiving hMSCs after ischemia compared with animals ...
13
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
... We performed a systematic literature search in July 2017 via PubMed to identify studies reporting original data on PACAP in relation to the BBB. The following search terms were used: pituitary adenylate ...
6
Accelerated Evolution of the Pituitary Adenylate Cyclase-Activating Polypeptide Precursor Gene During Human Origin
... H UMANS diverged from African apes ⵑ5–7 million Pituitary adenylate cyclase-activating polypeptide (PA- years ago (Goodman et al. 1998). Genetically, hu- CAP) is a well-studied ...
6
Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
... Pituitary adenylate cyclase-activating polypeptide (PACAP) is a member of the vasoactive intestinal pep- tide (VIP)/secretin/glucagon peptide family, which is widely expressed in humans ...
6
The pituitary adenylate cyclase–activating polypeptide is a physiological inhibitor of platelet activation
... The pituitary adenylate cyclase–activating polypeptide (PACAP) is a neuropeptide of the vasoactive intestinal peptide/secretin/glucagon ...peptide/pituitary adenylate ...
9
PACAP and its role in primary headaches
... cord. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are members of the VIP/secretin/growth hormone-releasing hormone/glucagon ...
7
Neuropeptide signaling and hydrocephalus: SCO with the flow
... the pituitary adenylate cyclase–activating polypeptide (PACAP) type I (PAC1) receptor gene results in abnormal development of the SCO and vel cells, leading to congenital hydrocephalus ...
6
Protective effects of PACAP in ischemia
... Pituitary adenylate cyclase activating polypeptide (PACAP) is an ubiquitous peptide involved, among others, in neurodevelopment, neuromodulation, neuroprotection, neurogenic ...
9
The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine
... Pituitary adenylate cyclase activating polypeptide (PACAP) is a potent endothelium independent vasodilator of vari- ous vascular beds, including cerebral arteries [44, ...
9
Localization and function of VIP and PACAP in the heart
... neuropeptide pituitary adenylate cyclase-activating peptide ...insulinotropic polypeptide and growth hormone-releasing factor ...
6
The Role of Cyclic AMP in the Octopaminergic Modulation of Flight Muscle in the Locust
... Effect of the adenylate cyclase activator forskolin The direct actions of the phosphodiesterase inhibitors on the DLM muscle of the locust are consistent with the idea that the octopamin[r] ...
16
Role of adenylate cyclase, guanylate cyclase enzyme and phosphodiesterase isozyme modulation in animal models of epilepsy.
... Phosphodiesterase enzymes regulate the degradation of cyclic AMP a product of the adenylate cyclase activation and could contribute to the pathophysiology of the seizure mechanisms (Conti, 1999). Seizures, ...
205
Adenylate-cyclase activity in platelets of patients with obsessive-compulsive disorder
... Abstract: Although the main biological hypothesis on the pathophysiology of obsessive-compulsive disorder (OCD) is centered on the serotonin system, indications are available that other neurotransmitters, and even second ...
5
Role of adenylate cyclase, guanylate cyclase enzyme and phosphodiesterase isozyme modulation in animal models of epilepsy.
... hormones, such as natriuretic factors, activate receptors that are associated with membrane bound guanylate cyclase (GC). Receptor activation of GC leads to the conversion of GTP to cGMP. Nitric oxide (NO) also ...
33
Activation of adenylate cyclase by cholera toxin in rat liver homogenates
... lowed by washing and addition of the complementary TABLE VII Effects of Isoproterenol and Glucagon on Adenylate Cyclase agent NAD or cholera toxin, respectively, in a Activity in Control[r] ...
10
Effects of cholera toxin on adenylate cyclase Studies with guanylylimidodiphosphate
... of adenylate cyclase by maximal concentrations of Gpp(NH)p, but not by submaximal concentrations, blocked the stimulatory effect of cholera ...the adenylate cyclase ...
6
High skeletal muscle adenylate cyclase in malignant hyperthermia
... biochemical marker for this myopathy has not previously been available; we found activity of adenylate cyclase and content of cyclic AMP to be abnormally high in skeletal muscle. Secondary modification of ...
7
Adenylate cyclase responsiveness to hormones in various portions of the human nephron
... measuring adenylate cyclase activity, using a single tubule in vitro ...increased adenylate cyclase activity in the convoluted and the straight proximal tubule, in the medullary and cortical ...
11
Suppressors of an Adenylate Cyclase Deletion in the Fission Yeast Schizosaccharomyces pombe
... Our examination of the mating phenotype and the station- ary-phase viability phenotype associated with the cgs1-10 and cgs1-1 mutations suggests that the cgs1-10 mutation has a lesser effect on Cgs1 function than does ...
10